314 related articles for article (PubMed ID: 18722730)
1. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.
Bebarta VS; Ferre RM; Peck M
J Emerg Med; 2010 Jul; 39(1):e81-3. PubMed ID: 18722730
[TBL] [Abstract][Full Text] [Related]
2. Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.
Goto CS; Feng SY
Pediatr Emerg Care; 2009 Apr; 25(4):273-9; quiz 280-2. PubMed ID: 19369845
[TBL] [Abstract][Full Text] [Related]
3. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
[TBL] [Abstract][Full Text] [Related]
4. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.
O'Brien NF; DeMott MC; Suchard JR; Clark RF; Peterson BM
Pediatr Emerg Care; 2009 Jul; 25(7):457-9. PubMed ID: 19606002
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
[TBL] [Abstract][Full Text] [Related]
6. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
Fazelat J; Teperman SH; Touger M
Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
[TBL] [Abstract][Full Text] [Related]
7. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation.
Camilleri C; Offerman S; Gosselin R; Albertson T
Clin Toxicol (Phila); 2005; 43(3):201-6. PubMed ID: 15902796
[TBL] [Abstract][Full Text] [Related]
8. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
Keating GM
BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
[TBL] [Abstract][Full Text] [Related]
9. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children.
Johnson PN; McGoodwin L; Banner W
Emerg Med J; 2008 Dec; 25(12):793-8. PubMed ID: 19033492
[TBL] [Abstract][Full Text] [Related]
10. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom.
Richardson WH; Goto CS; Gutglass DJ; Williams SR; Clark RF
Clin Toxicol (Phila); 2007; 45(5):472-5. PubMed ID: 17503249
[TBL] [Abstract][Full Text] [Related]
11. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.
Lavonas EJ; Schaeffer TH; Kokko J; Mlynarchek SL; Bogdan GM
BMC Emerg Med; 2009 Jun; 9():13. PubMed ID: 19545426
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model.
Offerman SR; Barry JD; Richardson WH; Tong T; Tanen D; Bush SP; Clark RF
Clin Toxicol (Phila); 2009 Jan; 47(1):61-8. PubMed ID: 19153852
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of Crotalidae Polyvalent Immune Fab in pediatric crotaline envenomations.
Pizon AF; Riley BD; LoVecchio F; Gill R
Acad Emerg Med; 2007 Apr; 14(4):373-6. PubMed ID: 17296804
[TBL] [Abstract][Full Text] [Related]
14. Rattlesnake envenomation to the face of an infant.
Richardson WH; Barry JD; Tong TC; Williams SR; Clark RF
Pediatr Emerg Care; 2005 Mar; 21(3):173-6. PubMed ID: 15744196
[TBL] [Abstract][Full Text] [Related]
15. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
[TBL] [Abstract][Full Text] [Related]
16. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
Cannon R; Ruha AM; Kashani J
Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
[TBL] [Abstract][Full Text] [Related]
17. Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center.
Weant KA; Bowers RC; Reed J; Braun KA; Dodd DM; Baker SN
Pharmacotherapy; 2012 May; 32(5):433-40. PubMed ID: 22467377
[TBL] [Abstract][Full Text] [Related]
18. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and use of snake antivenoms in the United States.
Dart RC; McNally J
Ann Emerg Med; 2001 Feb; 37(2):181-8. PubMed ID: 11174237
[TBL] [Abstract][Full Text] [Related]
20. Pygmy rattlesnake envenomation treated with Crotalidae Polyvalent Immune Fab Antivenom.
King AM; Crim WS; Menke NB; Pizon AF
Toxicon; 2012 Dec; 60(7):1287-9. PubMed ID: 22963729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
